A.P. Intoccia

506 total citations
14 papers, 438 citations indexed

About

A.P. Intoccia is a scholar working on Pharmacology, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, A.P. Intoccia has authored 14 papers receiving a total of 438 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pharmacology, 3 papers in Cellular and Molecular Neuroscience and 3 papers in Pharmacology. Recurrent topics in A.P. Intoccia's work include Synthesis and Biological Activity (3 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers) and Berberine and alkaloids research (2 papers). A.P. Intoccia is often cited by papers focused on Synthesis and Biological Activity (3 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers) and Berberine and alkaloids research (2 papers). A.P. Intoccia collaborates with scholars based in United States, South Korea and Canada. A.P. Intoccia's co-authors include Sidney S. Walkenstein, Wilfred J. Westlake, Jeffrey W. Dubb, Robert M. Stote, D. T. Walz, Don E. Griswold, Michael J. DiMartino, Robert G. Pendleton, John L. Sawyer and George Gessner and has published in prestigious journals such as Gastroenterology, The American Journal of Medicine and Clinical Chemistry.

In The Last Decade

A.P. Intoccia

13 papers receiving 366 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A.P. Intoccia United States 8 159 96 81 59 57 14 438
J. Moppert Switzerland 11 134 0.8× 76 0.8× 59 0.7× 75 1.3× 55 1.0× 25 472
Conny Bogentoft Sweden 14 67 0.4× 165 1.7× 38 0.5× 87 1.5× 51 0.9× 61 617
Fritz Lauterbach Germany 15 67 0.4× 254 2.6× 151 1.9× 50 0.8× 49 0.9× 54 606
Yoichi Sugawara Japan 13 120 0.8× 113 1.2× 68 0.8× 14 0.2× 51 0.9× 28 371
M. Wafik Gouda Saudi Arabia 16 91 0.6× 123 1.3× 66 0.8× 163 2.8× 50 0.9× 47 600
K. Dietzel Germany 9 190 1.2× 48 0.5× 67 0.8× 58 1.0× 59 1.0× 13 369
IKUO JOHNO Japan 10 44 0.3× 80 0.8× 53 0.7× 86 1.5× 49 0.9× 39 376
G. O. Breault United States 7 164 1.0× 39 0.4× 65 0.8× 30 0.5× 48 0.8× 10 351
G. Gothóni Finland 14 100 0.6× 96 1.0× 41 0.5× 22 0.4× 25 0.4× 25 488
B.D. Rush United States 12 97 0.6× 145 1.5× 113 1.4× 242 4.1× 41 0.7× 23 698

Countries citing papers authored by A.P. Intoccia

Since Specialization
Citations

This map shows the geographic impact of A.P. Intoccia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.P. Intoccia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.P. Intoccia more than expected).

Fields of papers citing papers by A.P. Intoccia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A.P. Intoccia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.P. Intoccia. The network helps show where A.P. Intoccia may publish in the future.

Co-authorship network of co-authors of A.P. Intoccia

This figure shows the co-authorship network connecting the top 25 collaborators of A.P. Intoccia. A scholar is included among the top collaborators of A.P. Intoccia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A.P. Intoccia. A.P. Intoccia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Walz, D. T., et al.. (1983). Biologic actions and pharmacokinetic studies of auranofin. The American Journal of Medicine. 75(6). 90–108. 75 indexed citations
2.
Matthews, William D., et al.. (1981). Correlation of [14C]muscimol concentration in rat brain with anticonvulsant activity. European Journal of Pharmacology. 69(3). 249–254. 8 indexed citations
3.
4.
5.
Pendleton, Robert G., et al.. (1979). Studies on SK&F 29661, an organ-specific inhibitor of phenylethanolamine N-methyltransferase.. PubMed. 208(1). 24–30. 31 indexed citations
6.
Intoccia, A.P., et al.. (1979). High-pressure Liquid Chromatographic analysis of Ticrynafen and one of its Metabolites in Urine and Serum. Journal of Pharmaceutical Sciences. 68(11). 1451–1453. 1 indexed citations
7.
Alexander, Fred, et al.. (1979). Studies with a PNMT inhibitor. Clinical Pharmacology & Therapeutics. 25(6). 837–843. 7 indexed citations
8.
Walkenstein, Sidney S., et al.. (1978). Bioavailability of cimetidine in man. Gastroenterology. 74(2). 360–365. 145 indexed citations
9.
Intoccia, A.P., Sidney S. Walkenstein, Gregory Joseph, et al.. (1978). Distribution in normal and inflammatory tissue of a new semisynthetic cephalosporin, SK&F 75073.. The Journal of Antibiotics. 31(11). 1188–1194. 6 indexed citations
10.
Walkenstein, Sidney S., et al.. (1977). High-Pressure Liquid Chromatographic Analysis of Cimetidine, a Histamine H2-Heceptor Antagonist, in Blood and Urine. Journal of Pharmaceutical Sciences. 66(8). 1148–1150. 120 indexed citations
11.
Walkenstein, Sidney S., et al.. (1974). Rapid Ultraviolet Procedure for Measuring Doxepin and Some Doxepin Metabolites in Human Urine. Clinical Chemistry. 20(6). 692–694. 4 indexed citations
12.
Walkenstein, Sidney S., et al.. (1973). Metabolism of the Antihypertensive Agent 1,4-Dihydro-2,6-dimethyl-4-(2-trifluoromethylphenyl)-3,5-pyridinedicarboxylic Acid Diethyl Ester. Journal of Pharmaceutical Sciences. 62(4). 580–584. 19 indexed citations
13.
Intoccia, A.P., et al.. (1972). The metabolism of l-N-benzyl-β-methoxy-3-trifluoromethylphenethylamine hydrochloride in the rat, dog, monkey and man. Neuropharmacology. 11(6). 761–775. 1 indexed citations
14.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. Moppert Breakdown of academic impact, for papers by Conny Bogentoft Breakdown of academic impact, for papers by Fritz Lauterbach Breakdown of academic impact, for papers by Yoichi Sugawara Breakdown of academic impact, for papers by M. Wafik Gouda Breakdown of academic impact, for papers by K. Dietzel Breakdown of academic impact, for papers by IKUO JOHNO Breakdown of academic impact, for papers by G. O. Breault Breakdown of academic impact, for papers by G. Gothóni Breakdown of academic impact, for papers by B.D. Rush
Rankless by CCL
2026